Clinical Gastroenterology Vol.31 No.07 ( Jun, 2016)

Thesis List

• 0 Editorial
  Junji Furuse

• 1 Cancer Chemotherapy : Standard Therapy & Clinical Trial
  Hiroshi Ishii

• 2 Imaging-based Evaluation for Tumor Response to Treatment, But Not for Decisions on Its Continuation
  Hiroaki Onaya

• 3 Chemotherapy for Senior Adult
  Kirio Kawai

• 4 Drug Resistance in Cancer Chemotherapy
  Hirofumi Nakayama

• 5 Molecular Targeted Therapy in Digestive Cancer
  Hiromichi Ebi

• 6 Complications of Gastroenterological Cancer and Chemotherapy : Gastrointestinal Obstruction and Perforation Obstruction of the Bile Duct
  Masao Toki

• 7 Chemotherapy for Cancer Patients with Hepatic or Renal Dysfunction
  Shunichiro Iwasawa

• 8 Countermeasures for Reactivation of Hepatitis B Virus by Chemotherapy
  Masafumi Ikeda

• 9 Management of Bone Metastasis with BMA in Patients with Gastrointestinal Cancer
  Haruo Iguchi

• 10 Medications for Palliative Care
  Etsuko Aruga

• 11 Psychological and Psychiatric Interventions for the Distress in Cancer Treatment
  Asao Ogawa

• 12 Issues around Chemotherapy from the Health-care Economic Standpoint
  Koichi Kawabuchi

• 13 Risk Management of Cancer Chemotherapy
  Keigo Komine

• 14 Perspective of Systemic Chemotherapy for Gastrointestinal Malignancy
  Narikazu Boku

• 15 Concept of Neoadjuvant and Adjuvant Therapy for Patients with Gastroenterological Cancer
  Masaki Nakamura

• 16 Role of Radiotherapy for Gastrointestinal Cancers
  Yoshinori Ito

• 17 Immunotherapy for Gastrointestinal Cancer：Evidence and Expectations
  Tetsuya Nakatsura

• 18-1 Fluoropyrimidines
  Makoto Ueno

• 18-2 Fundamental Knowledge of Platinum-based Drugs
  Naohiro Okano

• 18-3 Taxans
  Seigo Yukisawa

• 18-4 Irinotecan
  Masato Ozaka

• 18-5 Gemcitabine
  Kentaro Sudo

• 18-6 Angiogenesis Inhibitors：Bevacizumab and Ramucirumab
  Hiroki Yoshita

• 18-7 Kinase-inhibiting Drugs : Imatinib, Sorafenib, Sunitinib, Regorafenib
  Hiroyuki Arai

• 18-8 Anti-EGFR Antibody and Anti-HER2 Antibody
  Shinichiro Taira

• 18-9 Octreotide
  Satoshi Shimizu

• 18-10 Everolimus
  Yasushi Kojima

• 18-11 Streptozocin, Etoposide, Lonsurf
  Michitaka Nagase

• 19-1 Esophageal Cancer
  Hidekazu Hirano

• 19-2 Current Standard Chemotherapy in Metastatic Gastric Cancer
  Yoshiki Horie

• 19-3 Adjuvant and Neoadjuvant Chemotherapy for Gastric Cancer
  Keiichi Fujiya

• 19-4 Colorectal Cancer : Unresectable and Recurrence
  Hiromi Imataka

• 19-5 Evidence-based Adjuvant Chemotherapy for Colorectal Cancer
  Yuka Tamaoki

• 19-6 Chemotherapy for Hepatocellular Carcinoma
  Tatsuya Yamashita

• 19-7 Systemic Chemotherapy for Biliary Tract Cancer
  Masayuki Furukawa

• 19-8 Recent Progress in Pancreatic Cancer
  Mitsuhito Sasaki

• 19-9 Small Intestinal Tumor
  Satoshi Komiyama

• 19-10 Pharmacotherapies of Gastroenteropancreatic Neuroendocrine Neoplasms
  Keijiro Ueda

• 19-11 Small Intestinal Tumor
  Tetsuhito Muranaka

• 19-12 Gastrointestinal Lymphoma
  Masahiro Yokoyama

• 20-1 Myelosuppression
  Yukio Yoshida

• 20-2 Management Techniques of Side Effects -- Gastrointestinal Disorders
  Nozomi Okuno

• 20-3 Neuropathy : Chemotherapy‒induced Peripheral Neuropathy and Leukoencephalopathy
  Daisuke Naruge

• 20-4 Skin Disorder and Edema
  Mikiko Tohyama

• 20-5 Interstitial Lung Disease
  Takashi Ogura

• 20-6 Hepatic Disorder, Renal Disorder
  Eiichiro Suzuki

• 20-7 Cardiovascular Complications of Chemotherapy and its Monitoring
  Hideaki Yoshino

• 20-8 Infusion Reaction
  Shigeatsu Motoori